The number of plaque forming units (p.f.u.) of virus dispensed on to interferontreated monolayers in a plaque reduction assay has been assumed to follow a Poisson distribution with the mean estimated from plaque counts on untreated monolayers. From these considerations, plaque counts have been assigned weights and the probit regression line calculated by the method of maximum likelihood. A chisquare analysis of plaque reduction data indicates agreement with the calculated line and does not refute the assumptions leading to the use of Poisson weighting coefficients or a log-normal distribution of p.f.u. 'tolerances' to interferon. This implies that the most precise estimate of dose occurs where plaques develop from 27 of the added p.f.u. The calculation of a weighted probit regression line from interferon plaque reduction data has several advantages: all the data from an experiment can be properly utilized; the variance and confidence interval of the interferon titres can be obtained; a direct comparison of dose-responses and titres can be made between different samples; a measure of the reliability of an experiment can be obtained by chi-square analysis.
INTRODUCTION
The assay of interferon by the plaque reduction method is usually performed by exposing cell monolayers that have been treated with interferon to a virus challenge under conditions that lead to plaque formation. A decrease from the expected number of plaques, determined from untreated monolayers, is taken as a measure of interferon activity. By analogy with other forms of biological assay, interferon may be regarded as the stimulus and the virus plaque as the subject which responds.
The applicability of probit analysis to plaque reduction data of this type has been recognized (Gifford, Toy & Lindenmann, 1963 ) and this method is now widely used although the usual technique of probit regression must be modified for this type of problem. The purpose of the present paper is to state the assumptions of the probit method in terms of an interferon assay and to describe the weighting of the observations that is required in order to calculate a probit regression line. Implications of the weighting coefficient for the design of an experiment and treatment of the data are discussed. Data are presented to show that experimental results are consistent with the model.
THEORY
Quantal responses and the tolerance distribution. The response of a virus plaque to interferon is not strictly quantal since the size of the plaque is affected as well as its occurrence (Gifford et al. I963) . A similar situation arises when insects are exposed to a poison and may be classified as slightly affected, moribund or dead. Methods are available for the probit analysis of such semi-quantitative data. However, the ability to visualize and count a plaque may be conveniently used to convert the data to quantal responses. The information lost in this process can be minimized by counting as soon as plaques are fully developed on the control plates (Gifford et al. I963) .
The probability of the occurrence or non-occurrence of a plaque depends on the concentration of interferon to which the cell monolayers have been exposed (Lindenmann & Gifford, x963 ) and a normal distribution of tolerances of the 'plaque forming units' to the logarithm of the interferon concentration can be assumed. The method of probit analysis as described by Finney (~ 964) can then be viewed as a method for estimating the mean and variance of this tolerance distribution thereby characterizing the interferon preparation.
Probability of obtaining a given plaque count. In contrast to biological assays of the potency of toxins and the usual LD 5o determinations where the number of exposed subjects is known and responders to the stimulus are counted directly, in an interferon assay only the plaques that develop, or 'survivors', can be counted and the number of plaques that do not develop as a result of exposure of the cells to interferon must be estimated from control plates. This type of problem was recognized and solved by Wadley (I949) in the analysis of data on the control of immature stages of fruit flies; a general method for the estimation of the parameters of a tolerance distribution has been given by Finney (~949) . Since the number of plaques suppressed by interferon is not measured directly the argument that follows will deal with the number of plaques actually counted, s, and the probability, Q, that an individual plaque will develop. The conditional probability of observing s plaques on an interferontreated monolayer exposed to exactly n p.f.u, of virus is then where P --~-Q and represents the probability that a plaque will be suppressed. In practice the actual number, n, of p.f.u, to which a given monolayer was exposed is unknown and can be expected to follow a Poisson distribution in identical samples, volumes, of the challenge virus suspension. The probability of exposing a monolayer to exactly n p.f.u, from a Poisson distribution with mean N is N~e-S P(n I N) -n ! The probability of observing exactly s plaques on an interferon-treated plate is then the sum of these combined independent probabilities for each possible n and is given by
The limit of this expression is
in which s is seen to follow a Poisson distribution with mean and variance equal to NQ.
Since some degree of variation can be expected in the volumes of virus inoculum that are used for challenge and in the amount of virus adsorbed, the variance, NQ, must be regarded as a lower limit which probably will be exceeded in practice. It is important, however, to have an estimate for the variance ofs so that each observation can be given its proper weight in the calculation of the probit regression line. In the event that the variation of the plaque counts exceeds this expected variance the data will exhibit heterogeneity and the variances of the calculated parameters must be increased by a heterogeneity factor as described by Finney (~964).
The estimation of Q and N. In order to characterize an interferon preparation we want to estimate the probability, Q, of obtaining a plaque at particular doses of interferon. If q = s/N is an estimator of Q the probability of observing a particular q will equal the probability of observing the corresponding s (since N is constant) and the variance of q will be var s Q var q -N 2 -N"
The variance of the probit ofq is Q/NZ 2, where Z is the ordinate to the normal curve. The weight to be given to each probit then is NZ2/Q. Tables of the weighting coefficient w = Z2/Q have been published (Finney, I964; Wadley, I949) .
The mean, N, of the population of samples used for virus challenge, n, must be estimated from the number of plaques that develop on untreated control plates. Since the value taken for N affects all calculations it should be estimated with some accuracy and it may be desirable to increase the number of untreated control plates. If desired a correction for N can be calculated from the data as described by Wadley (I949) .
Calculation of the probit regression line. Having obtained an estimator of Q and a system of weights, the technique of probit analysis as described by Finney can be applied to obtain a probit regression line by the method of maximum likelihood. The process begins by fitting a provisional line to the data. Expected probits and weighting coefficients are taken from this line. The plaque count from each Petri plate at a particular interferon dilution is used to determine a working probit and a correction to the provisional line is then calculated. The calculated line may be used as a new provisional line and the process can be repeated until the lines do not change further. One cycle of calculations may be sufficient if the first provisional line is carefully chosen. Once a satisfactory line is obtained, the parameters of the regression equation, the dose giving the desired percentage point (PDDs0), chi square, and summary statistics are then calculated. If k dilutions of interferon are used in an experiment with three Petri dishes at each dilution and the data are used to estimate the two parameters of the probit regression line the experiment is considered to have 3k-2 degrees of freedom for the purpose of chi-square analysis.
RESULTS

Analysis of the data
When the plaque counts on interferon-treated plates are expressed as a percentage of the control number and plotted against the logarithm of the reciprocal of the interferon dilution, a typical sigmoidal dose response curve is obtained as shown in Fig. I . The scatter of the observations increases as the control value is approached, as expected from the variation in the number of p.f.u, to which the cell monolayers are actually exposed.
The probit transformation shown in Fig. 2 resulted in a linear relationship between probit and log dilution and it can be seen that the scatter of the individual probits increases at either end of the probit regression line. This increase in variation results from the fact that few 'plaques' will have their individual tolerances beyond extreme interferon concentrations and many more p.f.u, would have to be used in order to obtain a satisfactory estimator of Q in these regions. The noticeable scatter of the observations as the control value is approached is due to a combination of the two sources of variance and observations in this region carry the least weight.
The maximum likelihood computations for the regression line in Fig. 2 are shown in Table I . A provisional line has been fitted to the data and used to determine working probits and weighting coefficients. The calculation of an adjusted line is carried out as described by Finney (1964) . These computations have been automated and repeated adjustments, using the calculated line as the next provisional line, have been performed until the slope of the 
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line, b, differs by less than o.o0I from that previously calculated. It can be seen from Table i that the final iteration is well approximated by the first adjusted line in this instance. A test of the significance of the discrepancies can be made by calculating chi square as shown in Table 2 . Since each individual plaque count was expressed as a probit and regressed and two parameters have been estimated from the data the analysis will have 31 degrees of freedom. Chi square is within the expected range; hence, in this case the probit regression line is a satisfactory representation of the results of the experiment and it may be inferred that the assumption of a log-normal distribution of plaque tolerances to interferon and the assumptions leading to the use of Z2/Q as the weighting coefficient are not contradicated by the data. SNw (x-g) (y--j) = 165"77 ~ = SNwx/SNw = 2"o95 SNw (x-~) ~ = 12o'o4 j = Snwy/SNw = 4"412 b = I65"77/t2o'o4 = I"38I a = (3~-b£) = 1-5t8
In order to include more observations the assay was repeated using I-4 as the dilution factor. The plaque counts expressed as a percentage of the controls are shown in Fig. 3 and the increase in variation is apparent as the control value is approached. The maximum likelihood solution for this experiment has been approximated as described for the 'final iteration' of Expt I. The calculated value for chi square is 89'5 and with 7o degrees of freedom a value greater than 9o-5 could be expected from chance alone in 5 ~o of cases. The calculations pertaining to chi square are summarized in Table 3 for both experiments. ]('= I'518 + I'38IX. Q = probability of obtaining a plaque. 2 X(r~I) = 26"17 (0"70 < p < 0"75)
The probits of the observed plaque counts for Expt ~ are plotted in Fig. 4 and the tolerance bands about the regression line delimit with 95 ~ confidence the area in which approximately 9o ~ of the observations should fall based on a variance equal to the expected plaque count.
(After obtaining a variance corresponding to an expected plaque count the tolerance bands have been calculated assuming a normal distribution.) This is the equivalent of using the reciprocal of the weight given each expected probit as its variance. The tolerance bands are not symmetrical about the line and approach it most closely in an area representing less than 5o ~ plaque development. Although the observations are distributed as expected in the area representing the greatest plaque inhibition the observations fall below the regression line as the control value is approached. This could be due to a high estimate of the control value, N, or could possibly represent a compound type of dose-response curve (Finney, ] 964).
The mean and observed variance of the three plaque counts at each interferon dilution are shown in Fig. 5 . The average value of the ratio of the observed variance to the mean is I.O3, indicating that the use of a weighting coefficient based on a Poisson variance, even though other sources of error must be present, is not contradicted by these data. (Fig. 4) -The tolerance bands should enclose 90 % of the observed variances.
DISCUSSION
One object in performing a plaque reduction assay of interferon activity is to determine the dilution corresponding to a particular percentage response, usually 5o ~, and to characterize the interferon preparation by giving this dilution as the titre or 5o ~ plaque depressing dose (PDDs0). This follows the usual practice of reporting an LDs0, which is selected as the percentage point that can be most precisely estimated and that will allow the greatest discrimination between samples. These considerations are valid if the number of subjects (animals or insects) is known exactly. In this case the number of subjects responding to the stimulus will follow a binomial distribution and the weighting coefficient for the probit regression line will be w = Z~/PQ, which is symmetrical and reaches its maximum weight at P = 0"5 (50 ~ of subjects responding). (2) The solid fine represents the weighting coefficient given to probits when the number of subjects exposed to treatment is known exactly; the dashed fine represents the weighting coefficient given to probits when the number of exposed subjects follows a Poisson distribution.
In the case of an interferon assay, however, where the number of added p.f.u, varies and must be estimated, the number of plaques that develop at each interferon concentration is expected to follow a Poisson distribution and the weighting coefficient will be w --Z2/Q. This function is not symmetrical and its maximum value is achieved at a probit of 4"4 corresponding to the development or' survival' of 27"4 ~ of the added p.f.u. This is demonstrated in both the examples shown above where the entire range of responses from o to IOO ~ has been included. The most precisely estimated percentage point corresponds to )5, which is close to 4"4 ( Table I ). The two weighting coefficients are compared in Fig. 6 .
In order to characterize an interferon preparation we want to calculate the slope, b, and a percentage point of the dose response curve. Following Finney's notation, ifx is the logarithm of the interferon dilutions and m represents the dilution expected to give a certain percentage of plaque development, the variance of m will be
SNw(x-2)21
where ff is the weighted mean dosage of an experiment and S indicates summation (Finney, I964) . In order to minimize this variance we want to maximize SNw and establish ~ close to the chosen m. These considerations imply the selection of m to correspond to an expected plaque count of 27 % and the attempt, in so far as possible, to ' centre' the interferon dilu- its maximum value and an argument could be made for ' centring' an experiment about the expected probit of the mean rather than the maximum value. It can be anticipated from Fig. 6 that little change would result and this point has not been considered.) Calculations pertaining to the doses expected to give 5o and 27 % plaque development are shown in Table 3 . If only a single dilution or a few narrowly spaced dilutions are used in an experiment the estimation of the slope of the regression line, b, will be poor and the second term of V(m)
will become large. The variance (Finney, 1964) x-2) . In order to minimize this variance we want to look at w(Y-33) 2, where w = Z~/Q and 33 = 4"4; this function is shown in Fig. 7 . Maxima are present at Y = 3"I and Y = 5"6 corresponding to plaque counts of 2"9 and 72"6 ~ and represent the points most valuable for increasing the precision of b. The formulae for the variance of b and m are shown here to illustrate the regions of the probit scale giving the most information on these quantities; the effects of the estimation of N, Fieller's g factor, and heterogeneity of the data have not been considered (Finney, I964) . We are now able to approach the question of how to divide the available cell monolayers among different interferon dilutions where there is some knowledge of the dose-response curve, as may be the case with a given cell-virus system (Gifford, Mussett & Heller, ~964) or in repeated titration of a Jaboratory standard. In order to obtain the most information from an experiment, observations should be made where the quantities w = Z2/Q and w(Y-33) 2 are at a maximum. These functions can be compared by plotting them as a percentage of their maximum values and an arbitrary compromise selected where each is approximately 65 ~ to 7o ~ of its maximum (Fig. 8) . This occurs at Y = 3"6 and Y = 5"2, corresponding to expected plaque counts of 8 ~ and 58 ~. Since the use of only two concentrations gives no test of linearity, it is usually desirable to use three or more concentrations in an assay. If an estimate of the slope of the dose-response is available it will be possible to select the concentrations which, when centred on an expected plaque count of 2 7 ~, will cover the range of responses yielding the most information in as many steps as desired.
After obtaining a system of weights appropriate to interferon plaque reduction data a weighted probit regression line can be calculated. Treatment of the data in this manner offers several advantages. (0 All the data obtained from an experiment, when properly weighted, can be used in the determination of the regression line and observations need not be excluded
